Orexo AB (publ) announces it has appointed Dennis Urbaniak as Executive Vice President (EVP) of Digital Health, effective today. Dennis will lead the establishment of Orexo's global digital health business, initially through the development of two digital therapies, OXD01 (opioid use disorder) and OXD02 (alcohol use disorder), recently licensed from GAIA AG. Dennis will also be integral to Orexo's business development activities, particularly in the search for complementary digital health opportunities.